Research ArticleOpen Access

The Immunohistochemical Expression Ki-67 In Adenoid Cystic Carcinoma of The Salivary Glands

Mustafa Mohammed Abdulhussain*

Department of Oral Pathology, College of Dentistry, Al-Mustansiriyah University, Baghdad, Iraq

*Corresponding Author: 
Mustafa Mohammed Abdulhussain
  Department of Oral Pathology
  College of Dentistry, Al-Mustansiriyah University
  Baghdad
  E-mail: mustafa80moh@yahoo.com

Citation: Mustafa Mohammed Abdulhussain, (2018) The Immunohistochemical Expression Ki-67 In Adenoid Cystic Carcinoma of The Salivary Glands. J Dent Treat Oral Care 3(1): 101

Abstract

Adenoid cystic carcinomas are rare malignant tumors of salivary glands. They are occurring between the middle and elderly aged patients. They account for up to 30% of minor salivary gland tumors but only for about 6 % of parotid gland tumors.The aims were to evaluate the hisopathological immunopositivity of Ki-67 in Adenoid Cystic Carcinoma and to compare the results with Clinic pathologicalparameters and histological grades by using immunohistochemistry. Twenty cases have been studied histologically of Adenoid cystic carcinomas were retrieved for the period (2001 – 2011). The correlations between the clinical and pathological parameters were statistically analyzed by Chi-square test and the level of significance was 0.05 (two-sided). The high positivity expression of Ki-67 is independent prognostic factors of poor overall survival in ACC. In addition, more aggressive and different treatment should be provided to patients who show high expression of this marker.

Keywords: Ki-67; Immunohistochemistry; Salivary Glands Cancer

Introduction

Adenoid Cystic Carcinoma (ACC) is a rare and slow-growing epithelial malignant tumor of the salivary glands. It commonly occurs in minor salivary glands (30%) and nearly half of all oral ACC cases occur in the palate, so it comprises 5% to 10% of all salivary gland tumors [1]. In minor salivary glands, the incidence is equal in both sexes, but when it occurs in the submandibular glands, high frequent in women [2]. The progression of disease becomes more rapid once metastatic disease is present, and nearly within 2 years after developing metastases one third of patients die [3].

It shows three hisopathological patterns, cribriform, tubular and solid; the most common pattern is the cribriform pattern, in which the polygonal cells are small and uniform which are arranged in epithelial components and less frequently the malignant tumor shows a tubular or solid pattern. The tubular pattern is formed from different ducts that can be presented by one or two layers of cells which similar to the myoepithelial cells. The solid pattern is composed of solid epithelial islands with necrosis of the central areas; the cells are small, basophilic and hyperchromatic with a densely granulated nucleus and mitoses are rarely seen [4].

The immunohistochemical expression of Ki-67 in malignant tumor of salivary glands is considered as a marker for the proliferation rate of cells; the high frequency of metastasis and an unfavorable prognosis is usually related to an increased immunohistochemical expression of Ki-67 [5]. In immunohistochemical study, expression of Ki-67 is showed poor prognostic factor of ACC; however, the relationship between the survival of patients and the high immunohistochemical expression of this marker is not well-known [6]. Our study showed that the assessment of the immunohistochemical expression of Ki-67 in 20 cases of Adenoid Cystic Carcinoma, aiming to correlate between the proliferative rate and the clinic pathological parameters.

Materials and Methods

All cases with adenoid cystic carcinoma that were studied and diagnosed histologically within (2001- 2011) and then they were randomly selected from the file sheets of the department of Oral pathology, College of Dentistry, Baghdad University, Iraq. The clinical and pathological informations such as age, gender and lesion site were obtained from the patient files (chart). The tissue blocks of tumor were fixed in formalin and embedded in paraffin wax were used in this study. In each block, one section was stained with hematoxylin and eosin for histopathological diagnosis and other section was prepared on adhesive slides for detection of Ki-67 expression.

The immunohistochemical sections with malignant tumor tissues and hematoxylin-eosin slides were diagnosed by two pathologists and the grading of tumors were according to three growth patterns: cribriform, tubular, and solid. The tissue with paraffin blocks of cases were cut into pieces with 4 microns in thickness and dyed with immunohistochemical stains by using the method of anti-Ki - 67 (MIB-1 monoclonal antibody) labeled strepto-avidin-biotin. The positive controls had been done by using breast tissues and the negative controls by using some sections with non-immune serum. The scoring of all samples for Ki-67 immunoreativity and Statistical analysis were performed by SPSS program (ANOVA and T test). When the p-value was <0.05, the results were considered significant. The score of intensity to estimate the immunostaining of Ki-67 was represented by four score such as (1, no staining; 2, weak; 3, moderate; 4, strong). The proportion score was done by estimated fraction of positively stained tumor cells with this marker (1 <10%; 2 = 10 to 50%; 3 = 50 to 90%; 4 ≥90%). The assessments of statistical significance of the associations were done by Chi-square (χ2) test of homogeneity.

Results

In this retrospective study, twenty cases of Adenoid Cystic Carcinoma of salivary glands were used to detect the Ki-67. The mean age for patients with ACC was (44.8±12.5). According gender, (13) (65%) cases were males and (7) (35%) cases were females and also male to female ratio was (1.9: 1) (Table 1).

Age group Number of Male Percentage Number of Female Percentage Total Percentage
(<40) 5 38.5 4 57.1 9 45
(40-59) 5 38.5 2 28.6 7 35
(60+) 3 23 1 14.3 4 20
Total 13 65 7 35 20 100
Mean+/-SD 44.8 +/-12.5

Table 1: The incidence of Adenoid Cystic carcinoma according to age in both genders with percent

According to Site, Palate was the most affected site followed by the floor of the mouth and the submandibular glands (Figure 1).

Twenty cases of ACC with histological grading categorized according to growth pattern into: (8) cases (40%) were grade (I), (9) cases (45%) were grade (II) and (3) cases (15%) were grade (III) (Figure 2).

From all cases of ACC, (17) cases expressed Ki-67 immunopositive cell. The tumor cells were evaluated as Ki-67 positive when their nuclei are stain in brown color, with a diffuse granular pattern, but (3) cases expressed Ki-67 immunonegative nuclei.

The higher frequency in both male and female was in grade I, 6 (46.2%) and 4 (57.1%) respectively, but the lower frequency was in grade III, 3 (23.1%) for male and no tumor of grade III was found in female (Table 2).

The grading was evaluated according to the histological growth pattern such as cribriform, tubular and solid pattern. The average percentage of Ki – 67 immunostain was 35% in both grade I and grade II, while in grade III was 15% (Table 2).

The range of cells with positive stain was from 10% to 80%. In all of the positive stained samples, the mean percentage of Ki-67 immunoreactive cells was 33%.

The relationship between Ki-67 immunostaining and the grade level of malignant tumor (P= 0.83) was non-significant that seemed to be not going together with the increase in proliferation of tumor cells (Figure 3).

Grade Male Female Total
Frequency Percentage Frequency Percentage Frequency Percentage
Rade Ι 6 46.2 4 57.1 10 50
Rade ΙΙ 4 30.7 3 42.9 7 35
Rade ΙΙΙ 3 23.1 0 0 3 15
Otal 13 65 7 35 20 100

Table 2: The frequencies of Adenoid cystic carcinoma grading in both Male and Female

Discussion

The aim of this study was to identify prognostic marker of Adenoid cystic carcinoma by evaluating the relationship between immunohistochemical expressions and clinic pathologicaldata. ACC is extremely malignant rare tumor [7]. Its incidence may reach to up to 30% of minor salivary gland tumors and the palate is the most common site of this type of tumor [8]. According to age, ACC has a peak incidence in the fourth to sixth decades of life which comes in agreement with the results of other studies [9]. This may be defined as a result of prolong exposure to chemicals and other predisposing factors of cancer that lead to development of cancer. The mean age of patients with Adenoid cystic carcinoma was 44 years that accordance with many other studies such as Triantafillidou K et al., 2006 [1].

In regarding to gender, the frequency of male more than female; however, there are studies presenting a male predominance in ACC, but other studies presenting an equal gender distributions [10]. The neurological manifestations are a reflection of the predilection of the tumor to infiltrate and spread along and around the nerves which are often prominent features and may be extensive. The tumor cells of Adenoid cystic carcinoma are two types: cells of the lining of the duct and cells of myoepithelial type [1] (Figure 4).

Histologically, ACC can be classified into three growth patterns: cribriform, tubular and solid or busload pattern. Most of these tumors have architecture of all these three patterns more than one pattern and it is then categorized according to the more predominant histological pattern [11]. In addition to grading, there are many other important histological features are presence of tumor at surgical margins of lesion, primary location [12]. According to grading, 40% of ACC cases were detected in grade I, 45% were detected in grade II and 15% in grade III. There is not any correlation between the gender and grade of tumors and also no relationship between the age and grade of tumors. In the most other malignancies, the degree of malignancy of tumors can be related to the activity of carcinoma cells [13].

MIB-1 index (the numerical percentage of Ki-67 antigen positive cells used for evaluation of proliferative activity of Ki-67 antigen. In this retrospective study, 17 cases (85%) were immunohistochemically positive for Ki-67 and 3 cases (15%) were negative. The immunoreactive cells of Ki-67 ratio were 10% to 80%. This range is different in many other studies such as Kiyoshima et al. stated that this range from 0.4% to 27.2% of their cases [14]. While, Carlinfante, et al. showed low labeling index Ki-67 in 42% of their cases ranged from 3% to 15% [15].

In other than Adenoid cystic carcinoma such as (mucoepidermoid carcinoma and acinic cell carcinoma) with the histological pattern of tumor are related to Ki-67 expression in malignant cells haves been demonstrated, but this disagreement with this study between Ki-67 immunoreaction and grading of ACC [16]. In addition, other study stated results similar to our results such as: in 2001, Kiyoshima et al. did not find significant relationship between inmunohistochemical expression of Ki-67 and morphological growth pattern or clinical course of the tumors [15].

While, Norberg et al. showed that the immunopositivity of Ki-67 antigen correlated strongly with tumor grade (p= 0.053), and stating ratio greater than 10% [17] (Figure 5).

Many of articles revealed that Ki-67 expression in ACC most correlated with clinic pathologicalfactors such as age, sex, site of primary tumor, and grading of tumor. It was seen that Ki-67 expression to have non prognostic significance with grading of tumor [15]. Some studies stated that this index is a reliable marker for distinguishing between benign and malignant tumors of salivary glands [18].

In conclusion, the high immunihistochemical expression scoring of Ki-67 is not related to prognostic factors of poor overall survival of patients with ACC. Therefore, more aggressive and differentiated treatment should be provided to patients who show high expression of these markers.

Acknowledgements

We would like to thank all staff in Oncology Teaching Hospital and Teaching laboratories, Medical City, Bagdad on their continuous support to complete this article.

Recommendation

It is important to use large number of patients with this type of cancer and the results of other different studies should be correlated with our study to predict many other feathers of malignant cells.

References
  1. 1. Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Koufogiannis D (2006). Management of adenoid cystic carcinoma of minor salivary glands. J Oral Maxillofac Surg 64: 1114-20.
  2. 2. Gnepp DR (2001). Diagnostic surgical pathology of the head and neck. Philadelphia: WB Saunders. 379.
  3. 3. Spiro RH (1997). Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg. 174: 495-8.
  4. 4. Batsakis JG, Luna MA (1990). Histopathologic grading of salivary gland neoplasms: III. Adenoid cystic carcinomas. Ann Otol Rhinol Laryngol 99: 1007-09.
  5. 5. Goyal S, Singh UR, Sharma S, Kaur N (2014). Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer. Urol J 11(1): 1238-47.
  6. 6. Tang Y, Liang X, Zheng M, Zhu Z., et al (2010). Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma. Oral Oncol 46: 311-6..
  7. 7. Ishikawa YU, Ishii TO, Asuwa NO (1997). Adenoid Cystic Carcinoma origina¬ted from an anterior lingual minor salivary gland: Inmmunohistochemical and ultrastructural studies and review of the literature. J Oral Maxillofac Surg 55: 1460-9.
  8. 8. Rapidis AD, Givalos N, Gakiopoulou H, Faratzis G, Stavrianos SD., et al (2005) Adenoid cystic carcinoma of the head and neck, Clinic pathologicalanalysis of 23 patients and review of the literature. Oral Oncolog 41: 328-35.
  9. 9. Giannini PJ, Shetty KV, Horan SL, Reid WD, Litchmore LL., et al (2006). Adenoid cystic carcinoma of the buccal vestibule: A case report and review of the literature. Oral Oncol. 42.10:1029-32.
  10. 10. Konkemueller H, Eckardt A, Brachvoget P, Hausamen JE (2004). Adenoid cystic carcinoma of the head and neck a 20 years experience. Int J Oral Maxillofac Surg 33.1: 25-31.
  11. 11. Mils SE, Stenberg S (2004). Diagnostic surgical pathology. Philadelphia: Lippincott Williams and Wilkins. 946-7.
  12. 12. Szanto PA, Luna MA, Tortoledo ME, White RA (1984). Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 54: 1062-9.
  13. 13. Hideo K, Min Z, Shinobu M, Yoshihiro Y, Toshiko T., et al (2005). The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. J Oral Pathol Med 34: 602-7.
  14. 14. Kiyoshima T, Shima K, Kobayashi I, Matsuo K., et al (2001). Expression of P53 tumor suppressor gene in adenoid cystic and salivary glands. Oral Oncology 37: 315-22.
  15. 15. Carlinfante G, Lazzaretti M, Ferrari S, Bianchi B, Crafa P., et al (2005). P53, bcl-2 and Ki-67 expression in adenoid cystic carcinoma of the palate. A clinico-pathologic study of 21 cases with long-term follow-up. Pathol Res Pract 200: 791-9.
  16. 16. Suzzi MV, Alessi A, Bertarelli C, Cancellieri A, Procaccio L., et al (2005). Prognostic relevance of cell proliferation in major salivary gland carcinomas. Acta Otorhinolaryngol Ital. 25.3:161-8.
  17. 17. Norberg Spaak L, Dardick I, Ledin T (2000). Adenoid cystic carcinoma: use of cell proliferation, BCL-2 expression, histologic grade and clinical stage as predictors of clinical outcome. Head Neck 22: 489-97.
  18. 18. Zhu Q, Tipoe GL, White FH (1999). Proliferative activity as detected by immunostaining with Ki-67 and proliferating cell nuclear antigen in benign and malignant epithelial lesions of the human parotid gland. Anal Quant Cytol Histol 21: 336-42.

We welcome your research work...!!!Submit Manuscript